Insider · CIK 0002026600
Philip Tsai
officer
Files at IMNM (Immunome Inc.). First filing Nov 25, 2024, latest Mar 25, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$302k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMNM: Immunome Inc.
IMNMOct 9, 2026 · close 19.55
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Immunome Inc. | $104k 12,300 shares | +59% | - | |
| 50Moderate | Immunome Inc. | $198k 21,000 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 24, 2025 | IMNM Immunome Inc. | POpen-market purchase Common Stock | +12,300 | $8.42 | $104k | 33,300 | Mar 25, 2025 |
| Nov 21, 2024 | IMNM Immunome Inc. | POpen-market purchase Common Stock | +21,000 | $9.43 | $198k | 21,000 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.